Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Inmune Bio (INMB) Preferred Stock Liabilities (2023 - 2024)

Inmune Bio's Preferred Stock Liabilities history spans 2 years, with the latest figure at $799000.0 for Q2 2024.

  • For Q2 2024, Preferred Stock Liabilities changed N/A year-over-year to $799000.0; the TTM value through Jun 2024 reached $799000.0, changed N/A, while the annual FY2023 figure was $799000.0, N/A changed from the prior year.
  • Preferred Stock Liabilities for Q2 2024 was $799000.0 at Inmune Bio, roughly flat from $799000.0 in the prior quarter.
  • Across five years, Preferred Stock Liabilities topped out at $799000.0 in Q3 2023 and bottomed at $799000.0 in Q3 2023.